New book examines risks and benefits associated with new class of weight loss drugs

In journalist Johann Hari’s new book, “Magic Pill,” he explores the impact of new weight-loss drugs like Ozempic.

Hari shares his personal journey with Ozempic, detailing significant weight loss and a transformed relationship with food.

He said studies show these drugs are predicted to be used by a quarter of Americans within a few years.

They work by helping users feel full quickly and can lead to losing up to a quarter of body weight in six months.

While these drugs can reduce risks of diabetes, heart disease and other obesity-related conditions, Hari also highlights serious potential risks, such as increased chances of thyroid cancer and birth defects, raising concerns about long-term safety.

Hari’s book urges readers to weigh the benefits and risks carefully, considering the broader implications for society’s relationship with food and health.

Christopher Alston contributed to this report.